Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials

被引：0
|
作者：
Neyns, Bart
Weber, Jeffrey S.
Lebbe, Celeste
Maio, Michele
Harmankaya, Kaan
Hamid, Omid
O'Day, Steven
Chin, Kevin M.
McDowell, Diane Opatt
Cykowski, Lori
McHenry, Brent
Wolchok, Jedd D.
机构：
[1] UZ Brussel, Brussels, Belgium
[2] Comprehens Melanoma Res Ctr, H Lee Moffitt Canc Ctr, Tampa, FL USA
[3] Hop St Louis, Paris, France
[4] Ist Toscano Tumori, Univ Hosp Siena, Siena, Italy
[5] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, Vienna, Austria
[6] Angeles Clin & Res Inst, Los Angeles, CA USA
[7] Beverly Hills Canc Ctr, Beverly Hills, CA USA
[8] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[9] Bristol Myers Squibb Co, Lawrenceville, NJ USA
[10] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9059
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Association between immune-related adverse events (irAEs) and disease control or overall survival in patients (pts) with advanced melanoma treated with 10 mg/kg ipilimumab in three phase II clinical trials
    Lutzky, J.
    Wolchok, J.
    Hamid, O.
    Lebbe, C.
    Pehamberger, H.
    Linette, G.
    de Pril, V.
    Ibrahim, R.
    Hoos, A.
    O'Day, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
    Amin, Asim
    Lawson, David H.
    Salama, April K. S.
    Koon, Henry B.
    Guthrie, Troy, Jr.
    Thomas, Sajeve S.
    O'Day, Steven J.
    Shaheen, Montaser F.
    Zhang, Bin
    Francis, Stephen
    Hodi, F. Stephen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [23] Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma: Retrospective Analysis of Efficacy and Safety Data from a Phase II Trial
    Thompson, John A.
    Hamid, Omid
    Minor, David
    Amin, Asim
    Ron, Ilan G.
    Ridolfi, Ruggero
    Assi, Hazem
    Berman, David
    Siegel, Jonathan
    Weber, Jeffrey S.
    JOURNAL OF IMMUNOTHERAPY, 2012, 35 (01) : 73 - 77
  • [24] PHASE II STUDY OF IPILIMUMAB PLUS TEMOZOLOMIDE IN PATIENTS WITH METASTATIC MELANOMA
    Patel, S.
    Bassett, R.
    Hwu, W.
    Kim, K.
    Papadopoulos, N.
    Hwu, P.
    Bedikian, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 366 - 367
  • [25] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Patel, Sapna P.
    Kim, Dae Won
    Bassett, Roland L.
    Cain, Suzanne
    Washington, Edwina
    Hwu, Wen-Jen
    Kim, Kevin B.
    Papadopoulos, Nicholas E.
    Homsi, Jade
    Hwu, Patrick
    Bedikian, Agop Y.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1359 - 1366
  • [26] A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma
    Sapna P. Patel
    Dae Won Kim
    Roland L. Bassett
    Suzanne Cain
    Edwina Washington
    Wen-Jen Hwu
    Kevin B. Kim
    Nicholas E. Papadopoulos
    Jade Homsi
    Patrick Hwu
    Agop Y. Bedikian
    Cancer Immunology, Immunotherapy, 2017, 66 : 1359 - 1366
  • [27] Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme
    Altomonte, Maresa
    Di Giacomo, Anna Maria
    Queirolo, Paola
    Ascierto, Paolo Antonio
    Spagnolo, Francesco
    Bajetta, Emilio
    Calabro, Luana
    Danielli, Riccardo
    de Rosa, Francesco
    Maur, Michela
    Chiarion-Sileni, Vanna
    Ferrucci, Pier Francesco
    Giannarelli, Diana
    Testori, Alessandro
    Ridolfi, Ruggero
    Maio, Michele
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32
  • [28] Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme
    Maresa Altomonte
    Anna Maria Di Giacomo
    Paola Queirolo
    Paolo Antonio Ascierto
    Francesco Spagnolo
    Emilio Bajetta
    Luana Calabrò
    Riccardo Danielli
    Francesco de Rosa
    Michela Maur
    Vanna Chiarion-Sileni
    Pier Francesco Ferrucci
    Diana Giannarelli
    Alessandro Testori
    Ruggero Ridolfi
    Michele Maio
    Journal of Experimental & Clinical Cancer Research, 32
  • [29] A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma
    Laber, Damian A.
    Okeke, Roseline I.
    Arce-Lara, Carlos
    Taft, Beverly S.
    Schonard, Cassandra L.
    McMasters, Kelly M.
    Kloecker, Goetz H.
    Miller, Donald M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2006, 132 (09) : 611 - 616
  • [30] A phase II study of extended dose temozolomide and thalidomide in previously treated patients with metastatic melanoma
    Damian A. Laber
    Roseline I. Okeke
    Carlos Arce-Lara
    Beverly S. Taft
    Cassandra L. Schonard
    Kelly M. McMasters
    Goetz H. Kloecker
    Donald M. Miller
    Journal of Cancer Research and Clinical Oncology, 2006, 132 : 611 - 616
12345